Case report: A novel de novo variant of SCN8A in a child with benign convulsions with mild gastroenteritis

Hui Chen, Xiaoyan Li, Huaping Wu, Xiaolan Sun, Yuanyuan Che, Jian Zha, Ruiyan Wang, Xiongying Yu, Yong Chen, Jianmin ZhongFrontiers in Neurology 2022 · DOI

TL;DR

Researchers have identified a novel de novo mutation in the SCN8A gene in a child presenting with Benign Convulsions with mild Gastroenteritis (CwG). This marks the first time SCN8A—typically associated with severe epileptic encephalopathies—has been linked to this self-limiting, benign condition, significantly expanding the known clinical spectrum of the gene.

What Problem Does This Paper Address?

Benign Convulsions with mild Gastroenteritis (CwG) is a clinical phenomenon where previously healthy infants experience afebrile seizures during a mild bout of diarrhea or vomiting (often caused by rotavirus). While the prognosis is excellent and children usually do not require long-term medication, the underlying cause remains elusive.

Because CwG is more prevalent in East Asian populations and occasionally occurs in twins, scientists have long suspected a genetic component. However, previous searches for mutations in common "seizure genes" (like SCN1A or PRRT2) in CwG patients have largely come up empty. This paper investigates a specific case of recurrent CwG to see if Next-Generation Sequencing (NGS) can uncover a new genetic driver.

Methods

The authors conducted a clinical case study of a 19-month-old boy who experienced multiple generalized tonic-clonic seizures (GTCS) during two separate episodes of mild gastroenteritis.

To find the cause, they employed:

  • Clinical Diagnostics: EEG, brain MRI, and extensive blood/stool panels to rule out central nervous system infections, electrolyte imbalances, or hypoglycemia.
  • Next-Generation Sequencing (NGS): Genetic testing was performed on the child and both parents to identify rare or new mutations.
  • Bioinformatics Analysis: The identified variant was cross-referenced against global databases (gnomAD, ExAC, 1,000 Genomes) and analyzed using pathogenicity prediction tools (SIFT, MutationTaster, PolyPhen-2, CADD).
  • ACMG Classification: The variant was categorized according to the American College of Medical Genetics and Genomics guidelines.

Datasets

As a case report, the primary "dataset" is the clinical and genomic data of a single patient. However, the researchers utilized several large-scale genomic reference databases to confirm the rarity and predicted impact of the mutation:

  • gnomAD / ExAC: Used to ensure the variant was not present in the healthy general population.
  • 1,000 Genomes / ESP6500: Additional population frequency databases.

Key Insights and Ideas

  • The SCN8A Connection: SCN8A encodes the Nav1.6 voltage-gated sodium channel, which is vital for neuronal firing. Mutations in this gene are usually "bad news," typically resulting in severe Developmental and Epileptic Encephalopathy (DEE). Finding it in a benign, situation-specific condition like CwG is a major shift in how we view this gene's "phenotypic spectrum."
  • A Novel Variant: The specific mutation found—c.5503 C>G (p.Pro1835Ala)—is a de novo missense mutation, meaning it was not inherited from the parents but occurred spontaneously in the child.
  • Conserved Biology: The mutation affects a highly conserved amino acid region of the sodium channel, suggesting that even subtle changes in this critical protein can trigger seizures under the physiological stress of a gastrointestinal infection.
  • Clinical Differentiation: The paper emphasizes that CwG must be distinguished from chronic epilepsy. Because CwG has a good prognosis, identifying the genetic link helps clinicians avoid "overtreatment" with long-term anti-epileptic drugs that carry their own side effects.

Key Results

  • Genetic Discovery: The child was found to have a likely pathogenic de novo heterozygous mutation in SCN8A.
  • Clinical Outcome: Despite the seizures, the child’s EEG and MRI were normal. After a 17-month follow-up, the child showed normal motor and intellectual development and remained seizure-free without long-term medication.
  • Pathogenicity Scores: The variant received high scores for being deleterious across multiple computational models (e.g., a CADD score indicating high pathogenicity and a Z-score of 7.64 in gnomAD).

Limitations and Future Work

The primary limitation is that this is a single case report (N=1). While the genetic evidence is strong, one case is not enough to definitively prove that SCN8A is a common cause of CwG.

The authors suggest two main paths forward:

  1. Functional Studies: Future research should use "patch-clamp" techniques on cells expressing this specific mutation to determine if it causes a "gain-of-function" (making neurons hyper-excitable) or a "loss-of-function."
  2. Larger Cohorts: Screening more CwG patients for SCN8A mutations is necessary to establish how frequently this gene contributes to the disorder.
  3. Long-term Monitoring: Continued follow-up of this patient is required to ensure the condition remains benign as the child grows.

Summary updated

Abstract

Benign convulsions with mild gastroenteritis (CwG) is characterized by afebrile convulsions accompanied by mild gastroenteritis, and it can be considered after central nervous system infection, hypoglycemia, electrolyte disturbance, and moderate and severe dehydration are excluded. Previous studies have suggested that genetics may be involved in CWG. Herein, we reported a novel <i>de novo</i> variant of <i>SCN8A</i> in a child with CwG. This is the first report that <i>SCN8A</i> may be associated with CwG. Our report may provides evidence for the genetic etiology of CwG and expands the phenotypic and genetic spectrum of <i>SCN8A</i>-related disorders, which previously included severe developmental and epileptic encephalopathy (DEE) phenotype, benign epilepsy phenotype, spectrum of intermediate epilepsies, and patients with cognitive and/or behavioral disturbances without epilepsy. Phenotype of CwG has a good prognosis, and it does not require long-term antiepileptic therapy. Overtreatment should be avoided clinically. However, the conclusion needs to be further defined by long-term follow-up and similar clinical reports. In spite of this, our clinical observation provides possible evidence for future studies on the relationship between <i>SCN8A</i> and CwG.
BibTeX
@inproceedings{chen2022case,
  author = {Hui Chen and Xiaoyan Li and Huaping Wu and Xiaolan Sun and Yuanyuan Che and Jian Zha and Ruiyan Wang and Xiongying Yu and Yong Chen and Jianmin Zhong},
  title = {{Case report: A novel de novo variant of SCN8A in a child with benign convulsions with mild gastroenteritis}},
  booktitle = {Frontiers in Neurology},
  year = {2022},
  doi = {10.3389/fneur.2022.995513},
}
Figure